Healthcare Giant Takes Big Steps to Help the World’s Poorest

Sanofi successfully priced an inaugural sustainability-linked bond of EUR 650 million fixed-rate notes in its commitment to improving access to essential medicines in low to lower-middle-income countries. 

The French multinational healthcare company is expanding its social commitments via its global health nonprofit unit in an effort to have a more impactful global social responsibility strategy and offer support to vulnerable communities, as well as environmental conservation and diversity and inclusion. 

“Linking the cost of financing to the achievement of concrete targets in terms of access to medicines confirms our determination to put social responsibility at the center of our ambitions,” states Sandrine Bouttier-Stref, Sanofi’s global head of corporate social responsibility. 

The 650-million-euro fixed-rate note, due April 2029, is linked to a sustainability performance target: providing at least 1.5 million patients with essential medicines by the global health unit for the treatment of non-communicable diseases in 40 of the world’s poorest countries between 2022 and 2026.